ArticleHuman gene therapy2022

Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1.

Richard H Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.